MOG Antibody (NBP1-87458): Novus Biologicals
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients - Multiple Sclerosis and Related Disorders
IJMS | Free Full-Text | Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD | HTML
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations | Practical Neurology
What is MOGAD? | MOG Antibody Disease | SRNA
Frontiers | Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort
Figure 1 from Defining distinct features of anti-MOG antibody associated central nervous system demyelination | Semantic Scholar
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations | Practical Neurology
A multicenter comparison of MOG-IgG cell-based assays | Neurology
COVID-19, HHV6 and MOG antibody: A perfect storm - Journal of Neuroimmunology
The spectrum of MOG autoantibody-associated demyelinating diseases | Nature Reviews Neurology
Selective Depletion of Antigen-Specific Antibodies for the Treatment of Demyelinating Disease - ScienceDirect
Recent developments in MOG-IgG associated neurological disorders | Semantic Scholar
Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature - ScienceDirect
Overview of patient cohort, antibody status, and anti-MOG antibody... | Download Scientific Diagram
MOG antibody demyelination | Great Ormond Street Hospital
Overlapping autoimmune syndrome: A case of concomitant anti-NMDAR encephalitis and myelin oligodendrocyte glycoprotein (MOG) antibody disease - ScienceDirect
Pathology of myelin oligodendrocyte glycoprotein antibody–associated disease - Misu - 2021 - Clinical and Experimental Neuroimmunology - Wiley Online Library
MOG Polyclonal Antibody – Bioss
2018 RNDS — MOG Antibody-Associated Disease - YouTube
MOG Antibodies Tied to More Pediatric Conditions | MedPage Today
Serum level of IL-1β in patients with inflammatory demyelinating disease: Marked upregulation in the early acute phase of MOG antibody associated disease (MOGAD) - ScienceDirect
MOG antibody disease manifesting as progressive cognitive deterioration and behavioral changes with primary central nervous system vasculitis - Multiple Sclerosis and Related Disorders
Frontiers | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?
![Anti-MOG antibody [C2C3], C-term (GTX106283) | GeneTex](https://www.genetex.com/upload/website/prouct_img/normal/GTX106283/GTX106283_39701_20170705_IFA_R_19011506_183.jpg "Anti-MOG antibody [C2C3], C-term (GTX106283) | GeneTex")